News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Iriso shares fell 7.8% after the company postponed earnings while probing possible improper payments, leaving regulatory filing deadlines unchanged.
  • BofA warns the South Korean won may face renewed pressure as outbound direct investment jumps to $72 billion and portfolio outflows persist.
  • Dynatrace shares rose over 8% after Starboard Value disclosed a stake and pushed management for accelerated buybacks exceeding $2.5 billion.
  • UBS keeps an 'Attractive' rating on U.S. equities and reiterates an S&P 500 year-end target of 7,500 citing earnings and AI investment.
  • Citi lifts its global AI market estimate above $4.2 trillion by 2030, pointing to accelerating enterprise adoption.
  • Ghana rejected a proposed U.S. health agreement over clauses requiring sharing of sensitive health data.
  • Bank of Russia proposes mandatory yuan reserves for banks to curb volatility after yuan swap rates surged above 40%.

Latest Articles

Hinge Health CFO James Budge Sells $465K in Class A Shares

Hinge Health CFO James Budge Sells $465K in Class A Shares

Hinge Health Chief Financial Officer James Budge sold 10,906 Class A shares on March 23, 2026, for roughly $465,138 across three transactions executed under a Rule 10b5-1 trading plan. The company’s stock trades around $40.91, down about 12% year-to-date, while analysts hold mixed ratings and price targets amid strong recent revenue growth and an o…

Hinge Health President Disposes of $633,927 in Stock via 10b5-1 Plan

Hinge Health President Disposes of $633,927 in Stock via 10b5-1 Plan

James Pursley, president of Hinge Health, executed a pre-arranged sale of 15,000 Class A shares on March 23, 2026, generating roughly $633,927. The transactions were carried out under a Rule 10b5-1 plan and occurred in three tranches. Following the sales Pursley holds 732,104 Class A shares. Analysts continue to project an optimistic earnings outlo…

Bristow Director Disposes of 1,000 VTOL Shares in $45,000 Transaction

Bristow Director Disposes of 1,000 VTOL Shares in $45,000 Transaction

A Bristow Group Inc. director sold 1,000 shares of the company's common stock on March 23, 2026, at $45.00 per share, resulting in proceeds of $45,000. After the sale the director holds 17,455 shares. The transaction occurred as VTOL traded near $45.48 following a 42% one-year gain. Separately, Bristow reported fourth-quarter 2025 EPS of $0.61 vers…

DHT Has Liquidity—Position for a Q2 Payout Shock (Mid-term Long)

DHT Has Liquidity—Position for a Q2 Payout Shock (Mid-term Long)

DHT's balance-sheet improvement from recent VLCC sales and the arrival of newbuildings into the spot market materially increases the company's optionality for a large Q2 cash distribution. Shares trade at $18.64 with a market cap near $2.97B and a PE of 13.5; a disciplined mid-term long can capture upside if management leans into a special/boosted …

Why Santander's Reset Could Turn a 10x P/E into a Steep Bargain

Why Santander's Reset Could Turn a 10x P/E into a Steep Bargain

Santander trades near $11 with a market cap of $160B and a trailing P/E ~10.9. Recent noise around a UK mortgage exposure and legal inquiries has pressured sentiment. Under the surface, a diversified franchise, improving risk-weighted asset mix, and strategic initiatives in payments and digital banking argue for earnings recovery and multiple re-ra…

Turtle Beach Director Reports Insider Stock Sales; Board Member Resigns

Turtle Beach Director Reports Insider Stock Sales; Board Member Resigns

Turtle Beach Corp director Katherine Lee Scherping reported insider sales in two filings, with transactions occurring on March 20 and March 23, 2026, and the company also announced the resignation of director Terry Jimenez effective Friday. The filings indicate Scherping sold shares at prices between $11.50 and $11.62 for a reported total value of …

OnKure CEO Sells Small Block of Stock to Cover RSU Taxes Ahead of Earnings

OnKure CEO Sells Small Block of Stock to Cover RSU Taxes Ahead of Earnings

On March 23, 2026, OnKure Therapeutics President and CEO Nicholas A. Saccomano sold 86 shares of Class A common stock to satisfy tax-withholding from vested restricted stock units. The transaction totaled $357 at a weighted average price of $4.1565. Separately, H.C. Wainwright lowered its price target on the company to $27 from $34, citing an expec…